Should the FDA approve a drug despite uncertainties about its effectiveness?
- 5 views
- 0 support
- 2 comments
All comments
Joined in 2018
Close all
See the responses
Joined in 2022
603 comments posted |
24 of their responses were helpful to members
Rewards
-
Good Advisor
-
Contributor
-
Messenger
-
Explorer
-
Friend
Hide the responses
LizziB
Community managerGood advisor
LizziB
Community manager
Last activity on 04/21/2024 at 8:17 PM
Joined in 2022
603 comments posted | 6 in the Health and Medical News group
24 of their responses were helpful to members
Rewards
Good Advisor
Contributor
Messenger
Explorer
Friend
Hi everyone,
How are you today?
The Food and Drug Administration (FDA) has been in the news recently about whether they will approve a drug for the debilitating disease Amyotrophic lateral sclerosis (ALS). The reason why this is controversial is because advisors have recommended to approve the drug despite uncertainties about its effectiveness. The only trial contained less than 200 participants. But it could be very beneficial for those suffering from ALS seeing as it will be the first new drug for the disease in 5 years.
Should the FDA approve drugs that may help patients suffering from chronic or degenerative diseases without extensive trials? Would you take a drug with FDA approval but few trial participants? What do you think?
Please share your experiences and thoughts!
Take care,
Lizzi